Skip to main content
MASIMO CORP logo

MASIMO CORP - Investor Relations & Filings

Listed IPO Aug 2007
Ticker · MASI ISIN · US5747951003 LEI · 549300Q4A8JK0PIYCU29 US Manufacturing
Open in API
Filings indexed 1,270 across all filing types
Latest filing 2026-06-10 Regulatory Filings
Country US United States of America
Listing US MASI · 1 venue

Key figures FY2026

Period ended 2026-01-03 · USD
Headline annual figures for MASIMO CORP, fiscal year 2026, reported in USD, with the source filing for each figure.
Total Revenues USD 1.53B per the Annual Report filed 2026-05-01
Net Income USD -377.00M per the Annual Report filed 2026-05-01
Total Assets USD 5.07B per the Annual Report filed 2026-05-01
Total Equity USD 920.00M per the Annual Report filed 2026-05-01
Cash from Ops USD 763.00M per the Annual Report filed 2026-05-01

As reported by the issuer in the filings linked above. Figures are normalized for comparability; consult the source filing for the authoritative statement.

About MASIMO CORP

https://www.masimo.com/

Masimo is a global medical technology company that develops, manufactures, and markets a wide array of noninvasive patient monitoring technologies. The company's core offering is its proprietary Signal Extraction Technology (SET®) pulse oximetry, renowned for its ability to provide accurate measurements during patient motion and low peripheral perfusion. Masimo's product portfolio also includes advanced solutions for brain function monitoring (SedLine®), regional oximetry (O3®), and integrated patient monitoring and connectivity platforms like Root®. These technologies are designed to improve patient outcomes, enhance patient safety, and streamline clinical workflows in various healthcare settings, including hospitals, emergency medical services, and home care. The company focuses on creating innovative solutions that empower clinicians with reliable data to make critical care decisions.

Recent filings

Filing Released Lang Actions
S-8 POS
Regulatory Filings Classification · 85% confidence The document is a post‐effective amendment to SEC Form S-8 registration statements to deregister unsold shares under Masimo’s employee stock and retirement plans. It is a regulatory filing (Form S-8 POS) that does not itself report financial results or describe a new share issue, but rather withdraws previously registered securities. This falls under the general regulatory filings category (RNS).
2026-06-10 English
S-8 POS
Regulatory Filings Classification · 85% confidence The document is a post-effective amendment on Form S-8 filed with the SEC to deregister unsold employee plan shares following a merger. It is a compliance filing under the Securities Act rather than a financial report, earnings release, or share transaction notice. It does not itself report a share purchase or issuance but amends registration statements, making it a general SEC regulatory filing. Therefore, it best fits the Regulatory Filings (RNS) category.
2026-06-10 English
S-8 POS
Regulatory Filings Classification · 92% confidence The document is a Post-Effective Amendment to Form S-8 Registration Statements filed with the SEC. It deregisters unsold shares under various equity incentive and retirement plans following a merger. This is a regulatory compliance filing rather than a financial report, earnings release, or capital-raising announcement. It does not present substantive financial statements or serve as an investor presentation but is a typical SEC registration amendment. It therefore fits the general “Regulatory Filings” category as a miscellaneous SEC compliance filing.
2026-06-10 English
S-8 POS
Regulatory Filings Classification · 85% confidence The document is a Post-Effective Amendment to Form S-8 registration statements filed with the SEC to deregister unsold shares following a merger. It is a regulatory compliance filing (SEC Form S-8 amendment) rather than an actual financial report, earnings release, or capital issuance announcement. No category specifically covers Form S-8 amendments, so it falls under the general “Regulatory Filings” category.
2026-06-10 English
S-8 POS
Regulatory Filings Classification · 85% confidence The document is a Post-Effective Amendment to multiple Form S-8 Registration Statements filed with the SEC to deregister unsold shares following a merger. It is a regulatory compliance filing rather than an operational report, earnings release, or financial statement. Therefore it best fits the fallback category for miscellaneous SEC filings—Regulatory Filings (RNS).
2026-06-10 English
S-8 POS
Regulatory Filings Classification · 82% confidence The document is a post-effective amendment to Form S-8 registration statements under the Securities Act, used to deregister unsold securities. It is a routine SEC compliance filing and not an earnings release, annual or interim report, management discussion, or investor presentation. It does not involve share repurchases or detailed capital financing terms beyond deregistration, so it falls into the general Regulatory Filings category (RNS).
2026-06-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.